“…As highlighted above, miR-21 participates in infarction injuries, cardiac remodeling, atherosclerosis, arrhythmias, and cardiomyopathy, which are caused by infection or metabolic disorders (Thum et al, 2008;Thum, 2012Thum, , 2014van Rooij and Olson, 2012;Fiedler and Thum, 2013;Li et al, 2016;Dai et al, 2018;Zhou et al, 2018). This indicates its potential as a clinical therapeutic target.…”